Natexis SRL
Natexis reported total assets of 404,337 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Jul 2026).
The score of Natexis shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +63 % Total assets +214 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Natexis's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 23,210 € | ||||
| Equity | 149,888 € | ||||
| Cash | 25,921 € | ||||
| EBITDA | 43,993 € | ||||
| Total assets | 404,337 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Jul 2026
- Year ended 31 Dec 2024filed on 22 Sep 2025
- Year ended 31 Dec 2023filed on 01 Oct 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Natexis's financial analysis
- Solvency37.1%sector median: 37.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Natexis
Natexis's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0746.819.727
- VAT number
- BE0746819727
- Peppol
- Registered · 0208:0746819727 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 11 May 2020
- Registered office
- 1160 Auderghem
- Latest accounts
- 2025 · filed on 31 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Natexis (SRL) has been based in Auderghem since 2020, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 23,210 € and equity of 149,888 €; its revenue is not published. Its solvency stands at 37.1%, below the median of its sector (37.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Natexis
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie de Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Dewez Invest Retail sale of pharmaceutical products Visé · balance sheet 419,029 €
- Vereenooghe SEW Retail sale of pharmaceutical products Ledegem · balance sheet 426,561 €
- Pharma Buyl-Louise Retail sale of pharmaceutical products Ixelles · balance sheet 380,658 €
- Apotheek Hilde Lippens Retail sale of pharmaceutical products Knokke-Heist · balance sheet 378,020 €
- Yapharm Retail sale of pharmaceutical products Uccle · balance sheet 436,227 €
- Van de Keere Retail sale of pharmaceutical products Zottegem · balance sheet 366,717 €
- Goethals Retail sale of pharmaceutical products Kortrijk · balance sheet 475,802 €
Frequently asked questions about Natexis
What is the revenue of Natexis?
Natexis files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Natexis?
In Belgium, the VAT number is the company number prefixed with BE: BE0746819727 for Natexis, if the company is VAT-registered. Its company number (CBE) is 0746.819.727.
Where is the registered office of Natexis?
According to the CBE register, the registered office of Natexis is in 1160 Auderghem.
What is the equity of Natexis?
At the close of the 2025 financial year, the equity of Natexis amounts to 149,888 €, a solvency of 37.1% of total assets.
Who manages Natexis?
The register lists 1 active mandates at Natexis. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Natexis
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →